CA
MEDP icon

Clearstead Advisors’s Medpace MEDP Stock Holding History

Clearstead Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Sell
332
-651
-66% -$300K ﹤0.01% 1099
2026
Q1 		$472K Sell
983
-370
-27% -$189K ﹤0.01% 727
2025
Q4 		$760K Buy
1,353
+165
+14% +$93.7K 0.01% 542
2025
Q3 		$611K Buy
1,188
+858
+260% +$375K 0.01% 570
2025
Q2 		$103K Buy
330
+16
+5% +$4.8K ﹤0.01% 1053
2025
Q1 		$95.6K Buy
314
+79
+34% +$26.6K ﹤0.01% 1010
2024
Q4 		$77.9K Sell
235
-85
-27% -$28.8K ﹤0.01% 1071
2024
Q3 		$107K Sell
320
-1
-0.3% -$380 ﹤0.01% 1015
2024
Q2 		$132K Buy
321
+87
+37% +$34.5K ﹤0.01% 938
2024
Q1 		$90.9K Buy
234
+10
+4% +$3.52K ﹤0.01% 623
2023
Q4 		$68.7K Buy
224
+17
+8% +$4.59K ﹤0.01% 667
2023
Q3 		$50.1K Buy
207
+19
+10% +$4.86K ﹤0.01% 700
2023
Q2 		$45.2K Hold
188
– – ﹤0.01% 745
2023
Q1 		$35.4K Buy
188
+2
+1% +$414 ﹤0.01% 737
2022
Q4 		$39.5K Buy
186
+16
+9% +$3.2K ﹤0.01% 664
2022
Q3 		$27K Hold
170
– – ﹤0.01% 716
2022
Q2 		$25K Sell
170
-21
-11% -$3.04K ﹤0.01% 750
2022
Q1 		$31K Buy
191
+21
+12% +$3.46K ﹤0.01% 773
2021
Q4 		$37K Sell
170
-169
-50% -$35.4K ﹤0.01% 709
2021
Q3 		$64K Buy
339
+189
+126% +$34.5K ﹤0.01% 572
2021
Q2 		$26K Hold
150
– – ﹤0.01% 662
2021
Q1 		$25K Hold
150
– – ﹤0.01% 634
2020
Q4 		$21K Hold
150
– – ﹤0.01% 622
2020
Q3 		$17K Hold
150
– – ﹤0.01% 604
2020
Q2 		$14K Hold
150
– – ﹤0.01% 566
2020
Q1 		$11K Buy
+150
New +$13K ﹤0.01% 569

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Clearstead Advisors's MEDP Position: Q2 2026 in Review

Clearstead Advisors reduced its Medpace (MEDP) stake by 66% in Q2 2026, selling an estimated $300K and leaving 332 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

Clearstead Advisors first reported a position in MEDP in Q1 2020 and has held it in 26 quarters since. The position peaked at $760K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Clearstead Advisors held 332 shares of Medpace worth $176K as of Q2 2026.
  • Clearstead Advisors sold 651 Medpace shares in Q2 2026, an estimated $300K.
  • Medpace made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1099 holding.
  • Clearstead Advisors first reported a position in Medpace in Q1 2020 and has held it in 26 quarters since.
  • Clearstead Advisors's Medpace position peaked at $760K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.